How can patient registries facilitate guideline-based healthcare? A retrospective analysis of the CEDATA-GPGE registry for pediatric inflammatory bowel disease

被引:4
作者
Leiz, M. [1 ]
Knorr, M. [1 ]
Moon, K. [1 ]
Tischler, L. [1 ]
Sohrabi, K. [2 ]
Cantez, S. [3 ]
Daebritz, J. [4 ]
de Laffolie, J. [3 ]
van den Berg, N. [1 ]
机构
[1] Univ Med, Inst Community Med, Greifswald, Germany
[2] Tech Univ Appl Sci, Giessen, Germany
[3] Justus Liebig Univ, Gen Pediat & Neonatol, Giessen, Germany
[4] Greifswald Univ, Med Ctr, Dept Pediat, Greifswald, Germany
关键词
Pediatric inflammatory bowel disease (PIBD); Registry; Treatment guidelines; ULCERATIVE-COLITIS; CHILDREN; VALIDATION; QUALITY;
D O I
10.1186/s12913-023-09639-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundEarly diagnosis is mandatory for the medical care of children and adolescents with pediatric-onset inflammatory bowel disease (PIBD). International guidelines ('Porto criteria') of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition recommend medical diagnostic procedures in PIBD. Since 2004, German and Austrian pediatric gastroenterologists document diagnostic and treatment data in the patient registry CEDATA-GPGE on a voluntary basis. The aim of this retrospective study was to analyze whether the registry CEDATA-GPGE reflects the Porto criteria and to what extent diagnostic measures of PIBD according to the Porto criteria are documented.MethodsData of CEDATA-GPGE were analyzed for the period January 2014 to December 2018. Variables representing the Porto criteria for initial diagnostic were identified and categorized. The average of the number of measures documented in each category was calculated for the diagnoses CD, UC, and IBD-U. Differences between the diagnoses were tested by Chi-square test. Data on possible differences between data documented in the registry and diagnostic procedures that were actually performed were obtained via a sample survey.ResultsThere were 547 patients included in the analysis. The median age of patients with incident CD (n = 289) was 13.6 years (IQR: 11.2-15.2), of patients with UC (n = 212) 13.1 years (IQR: 10.4-14.8) and of patients with IBD-U (n = 46) 12.2 years (IQR: 8.6-14.7).The variables identified in the registry fully reflect the recommendations by the Porto criteria. Only the disease activity indices PUCAI and PCDAI were not directly provided by participants but calculated from obtained data. The category 'Case history' were documented for the largest part (78.0%), the category 'Imaging of the small bowel' were documented least frequently (39.1%). In patients with CD, the categories 'Imaging of the small bowel' (chi(2) = 20.7, Cramer-V = 0.2, p < 0.001) and 'Puberty stage' (chi(2) = 9.8, Cramer-V = 0.1, p < 0.05) were documented more often than in patients with UC and IBD-U.ConclusionThe registry fully reproduces the guideline's recommendations for the initial diagnosis of PIBD. The proportion of documented diagnostic examinations varied within the diagnostic categories and between the diagnoses. Despite technological innovations, time and personnel capacities at participating centers and study center are necessary to ensure reliable data entry and to enable researchers to derive important insights into guideline-based care.
引用
收藏
页数:12
相关论文
共 43 条
[1]  
[Anonymous], 2022, NEWSLETTER CEDATA GP
[2]  
[Anonymous], 2022, DIAGNOSTIC DATA HOSP
[3]   Epidemiology of Pediatric Inflammatory Bowel Disease: A Systematic Review of International Trends [J].
Benchimol, Eric I. ;
Fortinsky, Kyle J. ;
Gozdyra, Peter ;
Van den Heuvel, Meta ;
Van Limbergen, Johan ;
Griffiths, Anne M. .
INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) :423-439
[4]  
Blasini R, 2017, ENTWICKLUNG KLINISCH, V62
[5]   Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases: Results from a Clinical Practice Survey [J].
Bronsky, Jiri ;
de Ridder, Lissy ;
Ruemmele, Frank M. ;
Griffiths, Anne ;
Buderus, Stephan ;
Hradsky, Ondrej ;
Hauer, Almuthe Christina .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 68 (05) :676-683
[6]  
Buderus S., 2015, PADIATRIE, V27, P33, DOI [10.1007/s15014-015-0330-2, DOI 10.1007/S15014-015-0330-2]
[7]   Inflammatory Bowel Disease in Pediatric Patients [J].
Buderus, Stephan ;
Scholz, Dietmar ;
Behrens, Rolf ;
Classen, Martin ;
De Laffolie, Jan ;
Keller, Klaus-Michael ;
Zimmer, Klaus-Peter ;
Koletzko, Sibylle .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (08) :121-127
[8]  
Buhr HJ, 2015, ZBL CHIR, V140, P133
[9]  
CEDMO, MOD APP KIDS JUG CED
[10]   Significant advantages for first line treatment with TNF-alpha inhibitors in pediatric patients with inflammatory bowel disease - Data from the multicenter CEDATA-GPGE registry study [J].
Classen, Merle ;
de Laffolie, Jan ;
Classen, Martin ;
Schnell, Alexander ;
Sohrabi, Keywan ;
Hoerning, Andre .
FRONTIERS IN PEDIATRICS, 2022, 10